about
Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancerBetaPix-a enhances the activity of phospholipase Cgamma1 by binding SH3 domain in breast cancer.Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study.Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells.Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection.Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survivalEfficacy of an educational material on second primary cancer screening practice for cancer survivors: a randomized controlled trial.The 70-gene prognostic signature for korean breast cancer patients.Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic.Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosisDevelopment of novel breast cancer recurrence prediction model using support vector machine.Primary breast lymphoma: a single institution's experience.Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the MutationTubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute.Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.Distress and body image due to altered appearance in posttreatment and active treatment of breast cancer patients and in general population controls.Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?Comparison of morbidity of donor site following pedicled muscle-sparing latissimus dorsi flap versus extended latissimus dorsi flap breast reconstruction.HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy.Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations.Ileal metastasis of breast cancer in a patient with a BRCA2 gene mutation: report of a case.Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells.Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study.Methylene blue dye-related changes in the breast after sentinel lymph node localization.Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study.Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC).A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencingPrevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in KoreaThe clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging systemSmall node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy?
P50
Q21261223-CCABA93D-834A-48AD-A52B-0AC4AB05BFBCQ30160377-6F945E65-D1AB-4F17-BE31-4EB6F102D0EEQ30224535-D0052AC4-17E4-4548-8E3C-C9AAFDD8F80AQ33239655-7B228534-BCB9-4A01-9520-C6022AE316F1Q33330507-CF6BCD85-3A28-4496-946F-8DF9FB015D04Q33582645-C603B5FC-CB8E-4B73-8CEB-72D69ABB8504Q33699438-3052BB59-D185-4B4E-93BD-AD0D0CE1F423Q34221334-98E4800A-C037-472A-A5D8-6A4133C88228Q35142098-315BCADD-2C9D-4D4D-B3C9-FE83911FCFCBQ35142192-CF83AE81-99A1-4DD7-A000-E97DDB29BC1AQ35713864-D32C543C-E176-4307-9F5B-A2373169B96EQ36092049-ABAEA6D0-8A75-4C47-B0A6-05F97E9266C1Q36809603-F2BE46A8-FC53-43CB-AE2A-B14063D09BB4Q37240051-1B4C99ED-663D-40B3-B216-E3B1EC4AEADBQ38181083-A160400D-083B-49B0-97A9-8CC5FE122309Q38811312-82488E2F-24C0-479D-956C-74571B0C89A2Q39438411-03DBD9FD-85EA-413D-A902-1944DC139071Q39454199-1B9D356F-32FB-4C19-B160-85C9ABFB6454Q39712045-BFB66A57-E05B-4ED8-8624-4EA5E6DFE9A5Q39772964-95E13255-F985-4CFF-B2EA-9DCFF5F4DC6BQ39909527-C5CF43B1-1987-4B07-B19C-3D9C7311AB63Q40307227-28599F36-1D42-4332-962E-B415A8C304EAQ40453022-57340950-4BCF-48F9-9C4E-15623E2E58CBQ41449756-EEE86566-49FD-4D10-A86C-690B54CD292AQ43231278-C07F2FAD-BC1B-4BC7-B366-881B3F1F5F4EQ44629219-7186161C-8DF3-4808-932D-5A41567EDD82Q45342692-D4C27DD1-9752-430A-92D6-0AD51B9787A1Q45903150-99DE706A-AB61-4674-81EA-CD3A820EB62FQ48863793-FA2D8BB5-463C-421F-B243-CC0CD284B26AQ49250319-68AB92B1-4D88-4CE0-8E75-49B6F77BA970Q49677679-03576DBA-5DED-45C6-A682-967D3D58AFA4Q50264612-CA5A27AB-3720-48D1-BE95-4C38A63423D9Q53264917-536F6FED-ADD6-4579-BED5-617EAF93D6CCQ53446414-CF284423-FEF2-4BCC-8C5C-DC5232D69928Q53619056-8C741A40-59BE-45F8-887F-76CF55954F2AQ54453869-6A62E9FF-3A19-44CD-B5E5-69F6155DCE15Q57577799-FC768D7C-3802-4C72-A3B7-AF58DDE08063Q57801648-19A3A166-0689-4734-AB83-0C15D28EDA4DQ81873710-51C4EEAA-F641-4E3A-8C5F-3D4EA41F7595Q83309717-37B55961-EE46-41B6-AAED-8A38B4066B00
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeong Eon Lee
@ast
Jeong Eon Lee
@en
Jeong Eon Lee
@es
Jeong Eon Lee
@sl
type
label
Jeong Eon Lee
@ast
Jeong Eon Lee
@en
Jeong Eon Lee
@es
Jeong Eon Lee
@sl
prefLabel
Jeong Eon Lee
@ast
Jeong Eon Lee
@en
Jeong Eon Lee
@es
Jeong Eon Lee
@sl
P106
P1153
34667876400
P31
P496
0000-0003-0037-2456